Aileron Therapeutics Inc (ALRN)
3.57
-0.26
(-6.79%)
USD |
NASDAQ |
Nov 13, 16:00
3.65
+0.08
(+2.24%)
After-Hours: 20:00
Aileron Therapeutics Max Drawdown (5Y): 99.06% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.06% |
| September 30, 2024 | 99.06% |
| August 31, 2024 | 99.06% |
| July 31, 2024 | 99.06% |
| June 30, 2024 | 99.06% |
| May 31, 2024 | 99.06% |
| April 30, 2024 | 99.06% |
| March 31, 2024 | 99.06% |
| February 29, 2024 | 99.06% |
| January 31, 2024 | 99.06% |
| December 31, 2023 | 99.06% |
| November 30, 2023 | 99.06% |
| October 31, 2023 | 99.06% |
| September 30, 2023 | 99.06% |
| August 31, 2023 | 99.06% |
| July 31, 2023 | 99.06% |
| June 30, 2023 | 99.06% |
| May 31, 2023 | 99.06% |
| April 30, 2023 | 99.06% |
| March 31, 2023 | 99.06% |
| February 28, 2023 | 99.06% |
| January 31, 2023 | 99.06% |
| December 31, 2022 | 99.06% |
| November 30, 2022 | 99.06% |
| October 31, 2022 | 99.06% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.06% |
| August 31, 2022 | 99.06% |
| July 31, 2022 | 98.78% |
| June 30, 2022 | 98.26% |
| May 31, 2022 | 98.05% |
| April 30, 2022 | 98.05% |
| March 31, 2022 | 98.05% |
| February 28, 2022 | 98.05% |
| January 31, 2022 | 98.05% |
| December 31, 2021 | 98.05% |
| November 30, 2021 | 98.05% |
| October 31, 2021 | 98.05% |
| September 30, 2021 | 98.05% |
| August 31, 2021 | 98.05% |
| July 31, 2021 | 98.05% |
| June 30, 2021 | 98.05% |
| May 31, 2021 | 98.05% |
| April 30, 2021 | 98.05% |
| March 31, 2021 | 98.05% |
| February 28, 2021 | 98.05% |
| January 31, 2021 | 98.05% |
| December 31, 2020 | 98.05% |
| November 30, 2020 | 98.05% |
| October 31, 2020 | 98.05% |
| September 30, 2020 | 98.05% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.25%
Minimum
Nov 2019
99.06%
Maximum
Aug 2022
98.47%
Average
98.05%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -46.75 |
| Beta (5Y) | 2.348 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.5% |
| Historical Sharpe Ratio (5Y) | -0.1411 |
| Historical Sortino (5Y) | -0.3617 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.33% |